A systematic and reverse vaccinology approach to design novel subunit vaccines against Dengue virus type-1 (DENV-1) and human Papillomavirus-16 (HPV-16)
Open Access
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Informatics in Medicine Unlocked
- Vol. 19
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccinationScience Translational Medicine, 2015
- Dengue vaccineHuman Vaccines & Immunotherapeutics, 2014
- Call to Action for Dengue Vaccine FailureEmerging Infectious Diseases, 2013
- Vaccine failures after active immunisation against tick-borne encephalitisVaccine, 2010
- Dengue NS1 antigen detection: A useful tool in early diagnosis of dengue virus infectionIndian Journal of Medical Microbiology, 2010
- Conserved Motifs within Ebola and Marburg Virus VP40 Proteins Are Important for Stability, Localization, and Subsequent Budding of Virus-Like ParticlesJournal of Virology, 2010
- Evaluation of an Enzyme Immunoassay for Detection of Dengue Virus NS1 Antigen in Human SerumClinical and Vaccine Immunology, 2006
- Structure of the dengue virus envelope protein after membrane fusionNature, 2004
- Dengue and dengue haemorrhagic feverThe Lancet, 1998
- Dengue/Dengue Hemorrhagic Fever: The Emergence of a Global Health ProblemEmerging Infectious Diseases, 1995